1. Home

Competition watchdog to probe HRT medication rights sale

 
• By James Stent

The CMA has announced the launch of a merger inquiry into manufacturer Viatris’s sale of “certain rights” to two of its HRT drugs to Theramex.

breaking
HRT medication
In December, Theramex said its purchase of Viatris’s UK rights was “subject to regulatory approval”
James Stent

Read more by James Stent

James Stent joined C+D as a digital reporter in May 2023 from the South African human rights news agency GroundUp, where he was senior reporter and consultant editor.

Latest from News

More from Clinical